News
Interested participants have until 17 March 2018 to submit abstracts for oral or poster presentations at the International Conference on the Challenges Faced by Technical and Scientific Support ...
WALTHAM, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing life-transforming therapeutics for people ...
PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Lysogene (Paris:LYS) (FR0013233475 – LYS), a leading, biopharmaceutical company pioneering gene therapy technologies to treat central ...
BOSTON--(BUSINESS WIRE)-- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback